Case Study | November 04, 2010

Help for Detecting Prostate Disease

Radiology and urology team up for successful results

TRIM Biopsy

DynaLOC Targeting

Radiology and Urology team up for successful results.  Radiologist John Feller, M.D., medical director of Desert Medical Imaging, and local urologists have joined forces to test a promising new way to detect and diagnose prostate disease.

When a traditional transrectal ultrasound (TRUS) biopsy proves negative for the presence of disease, yet a patient's PSA levels (prostate-specific antigen) continue to rise, magnetic resonance imaging's (MRI) excellent soft tissue imaging quality may be the answer to a difficult diagnosis for a certain subset of patients.

MRI-guided prostate biopsy
DynaCAD for Prostate and DynaTRIM, both part of Invivo's Prostate Clinical Solution, give physicians the tools to perform real-time analysis of prostate MRI studies and the support for an MRI-guided prostate biopsy.

Initial experiences by Feller have shown positive results.  The ability to identify metabolically active areas that look suspicious for prostate disease has improved.

A Simple, Targeted Procedure
Following a diagnostic MRI to confirm the presence of suspicious tumor(s), the patient is placed on the scanner in a prone position and the MR-compatible biopsy device, DynaTRIM, is inserted into the rectum.  "The DynaTRIM needle guide is much smaller (approximately 1/4 the circumference) than the endorectal probe used for TRUS biopsies," comments Feller, "and is so well tolerated that it seems to preclude the need for local anesthetic."

A new scan confirms the guide's position and Feller and the urologist then plan the biopsy.  "Using the DynaCAD's DynaLOC localization software, this is really very simple," says Feller. "There are three different coordinates - a couple of degree measurements - and length measurements that are quickly generated by the software."

The DynaTRIM is adjusted and the urologist steps up to perform the actual biopsies.  With this targeted approach, only a few core samples are required.

Proof is in the results
For patient George LaVie, the MRI-guided prostate biopsy confirmed what his TRUS biopsy could not.  Feller notes, "You'd never have been able to hit this with a needle under ultrasound guidance because it was up behind some bones in the pelvis called the pubic symphysis."

"In Mr. LaVie's case," he continues, "we took cores from just four different locations plus a second core from one location by angulating the needle guide a couple of degrees."

Pathology results confirmed the presence of cancer and Mr. LaVie underwent a successful prostatectomy.

Dr. Feller is a firm believer in the potential of this new technology. "Many times, when new technology like this is rolled out," he says, "it is very complicated and difficult to operate.  This isn't anything like that.  This can be done in an out-patient imaging center where the key ingredient is teamwork between the urologist and radiologist."

This case study was supplied by Invivo Corp.

Invivo Customer Service, Gainesville, Fla.
800.331.3220
www.invivocorp.com

Related Content

MRI and Computer Modeling Reveals How Wrist Bones Move

Using fast MRI, UC Davis researchers scanned left and right wrists of men and women and used the data to build computer models of the movement of wrist bones. The data could help understand wrist injuries such as carpal tunnel syndrome. Image courtesy of Brent Foster and Abhijit Chaudhari, UC Davis.

News | Magnetic Resonance Imaging (MRI) | February 19, 2019
In a just-published Journal of Biomechanics article, the researchers proved a longtime assumption about individuals'...
Siemens Healthineers Demonstrates Artificial Intelligence, Healthcare Digitalization at HIMSS19
News | Artificial Intelligence | February 13, 2019
February 13, 2019 — At the 2019 Healthcare Information and Management Systems Society (HIMSS) global conference and e
Micro-Ultrasound and Artificial Intelligence Combining to Detect Prostate Cancer
News | Prostate Cancer | February 12, 2019
Cambridge Consultants has partnered with Exact Imaging, makers of the ExactVu micro-ultrasound platform, as the two...
Fujifilm Launches Latest Synapse 3D Version at HIMSS 2019

The new Intravoxel Incoherent Motion (IVIM) MR application in Synapse 3D

Technology | Advanced Visualization | February 08, 2019
Fujifilm Medical Systems U.S.A. will debut the latest version of its Synapse 3D solution at the Healthcare Information...
Study Assesses Risk of MRI Exams for Patients With Tattoos
News | Magnetic Resonance Imaging (MRI) | February 01, 2019
A new European study concluded that magnetic resonance imaging (MRI) exams pose little risk for people with tattoos,...
FDA Clears Perspectum's MRCP+ Digital Biliary Tree Viewer
Technology | Magnetic Resonance Imaging (MRI) | January 24, 2019
Perspectum Diagnostics received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its MRCP+...
Novel Technique May Significantly Reduce Breast Biopsies
News | Breast Biopsy Systems | January 17, 2019
A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce...
Machine Learning Uncovers New Insights Into Human Brain Through fMRI
News | Neuro Imaging | January 11, 2019
An interdisciplinary research team led by scientists from the National University of Singapore (NUS) has successfully...